Lung Cancer Screening Risks Australia | MJA Warning
Explore risks of Australia's lung cancer screening program from recent MJA research by Curtin Prof Fraser Brims, including incidental findings, COPD discovery, and calls for workforce boosts.
No reviews yet. Be the first to rate Fraser!
Professor Fraser Brims is a Professor in the Curtin Medical School within the Faculty of Health Sciences at Curtin University. He holds the qualifications MBChB, MRCP, MD and FRACP. Professor Brims serves as Director of Early Years Clinical Skills at Curtin University Medical School. He is also a Consultant Respiratory Physician at Sir Charles Gairdner Hospital, Deputy Director of the Institute for Respiratory Health and Chair of the Western Australian Mesothelioma Registry.
His research focuses on respiratory and occupational medicine, with particular emphasis on asbestos-related lung disease, mesothelioma and the detection of early lung cancer using low-dose CT scans. Professor Brims has contributed to key publications in these areas, including a 2016 paper on a novel clinical prediction model for prognosis in malignant pleural mesothelioma. He has been recognised with awards such as the 2026 Lung Health Legend award for his contributions to respiratory medicine and research. Professor Brims maintains an active academic profile with over 3,300 citations on Google Scholar for work in respiratory and occupational medicine.
Professional Email: null
Explore risks of Australia's lung cancer screening program from recent MJA research by Curtin Prof Fraser Brims, including incidental findings, COPD discovery, and calls for workforce boosts.
Curtin University's MJA study reveals Australia's National Lung Cancer Screening Program (NLCSP) faces risks from care gaps without urgent investments in MDTs, nurses, and registries. Explore the findings.